TB-500 contributes to tendon repair through a different and complementary pathway
References 1 Journal of Pharmacology and Experimental Therapeutics (PubMed)McCoy et al
Because it avoids those receptors, AOD 9604 does not elevate IGF-1 levels, does not affect blood sugar regulation, and does not carry the risks associated with exogenous growth hormone use
10.1073/pnas.191189098 369 LiJ.UverskyV
This likely reflects the balancing effects of GLP-1 and GIP receptor activation, including glucose-dependent insulin secretion and reduced energy intake
Modulation of these molecular mechanisms leads to a significant inhibition of cell viability, colony formation, and cell migration, ultimately contributing to apoptosis and increased sensitivity to radiation therapy 30 (Figure 3)